A Q&A with ‘Rising Leader’ Therese Liechtenstein
Therese was selected as one of the top 30 Rising Leaders in the 3rd annual listing of In Vivo’s ‘Rising Leaders’ 2022.
Tag Archive for: Invivo
What Next After A Year Of Innovation And Growth?
As part of its ‘Pharma Outlook for 2022’, leading healthcare publication, In Vivo, explored the outlook for US and EU venture capital funding in biopharma. Asking whether the sector can keep the momentum going for investments, it drew on the experience and insight of prominent investors [many among them our clients,] to provide comment on […]
30 Rising Leaders In The Life Sciences
Check out In Vivo’s list of “ones to watch” in Biopharma and Medtech. Optimum clients Derk Arts, Castor CEO, Jason Foster, Ori Biotech CEO and Greg Mullen, Theragnostics CEO recognised for “bringing something new to the game”.
